ADIL
Adial Pharmaceuticals Inc

8,580
Loading...
Loading...
News
all
press releases
All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to Buy
Adial Pharmaceuticals (ADIL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·14d ago
News Placeholder
More News
News Placeholder
Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why
Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
News Placeholder
Retail Traders Flock To Adial Pharma After Patent News Sends Shares Soaring
Adial Pharmaceuticals jumped to its highest level since February after receiving a U.S. patent for its precision medicine approach to treating addiction. The patent supports the use of AD04 in patients with specific genetic markers.
Stocktwits·5mo ago
News Placeholder
EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder
Adial Pharmaceuticals progresses to the second cohort in the AD04 pharmacokinetics study for Alcohol Use Disorder. This study, involving up to 30 healthy volunteers, will provide critical insights...
Benzinga·1y ago
News Placeholder
EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
Adial Pharmaceuticals publishes Phase 3 ONWARD study results in the European Journal of Internal Medicine. The study reveals AD04 significantly reduces heavy drinking days, with adverse events...
Benzinga·1y ago
News Placeholder
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8...
Benzinga·1y ago
News Placeholder
12 acciones de salud en movimiento durante la preapertura del 10/04/2024
Acciones al alza Jaguar Health (NASDAQ:JAGX) avanzaron un 43,99% para establecerse en los 0,13 d lares durante la sesi n del pre-market del mi rcoles. Adial Pharmaceuticals (NASDAQ:ADIL) ganaron un...
Benzinga·1y ago
News Placeholder
Adial Pharmaceuticals reports FY results
Adial Pharmaceuticals reports FY results...
SeekingAlpha.com: All News·1y ago
News Placeholder
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Received Favorable Feedback from US and EU Regulatory Agencies Advancing Discussions with Potential Strategic Partners Received $4.3 Million in Gross Proceeds from Warrant Exercises Subsequent to...
Globe Newswire·1y ago
News Placeholder
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Up 275.8% in March
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest...
Zolmax·1y ago

Latest ADIL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.